Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medavail Holdings, Inc. (MDVLQ)
:MDVLQ
Holding MDVLQ?
Track your performance easily
MDVLQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.15 - $3.86
Previous CloseN/A
Volume3.00
Average Volume (3M)86.00
Market Cap
$161.00
Enterprise ValueN/A
Total Cash (Recent Filing)$8.85M
Total Debt (Recent Filing)$12.48M
Price to Earnings (P/E)―
Beta-216.86
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,613,911
10 Day Avg. Volume1
30 Day Avg. Volume86
Standard Deviation25.70
R-Squared0.02
Alpha3.97
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
2.96% Other Institutional Investors
97.04% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDVLQ FAQ
What was Medavail Holdings, Inc.’s price range in the past 12 months?
Medavail Holdings, Inc. lowest stock price was $1.15 and its highest was $3.86 in the past 12 months.
What is Medavail Holdings, Inc.’s market cap?
Medavail Holdings, Inc.’s market cap is $161.00.
When is Medavail Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Medavail Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Medavail Holdings, Inc. overvalued?
According to Wall Street analysts Medavail Holdings, Inc.’s price is currently Overvalued.
Does Medavail Holdings, Inc. pay dividends?
Medavail Holdings, Inc. does not currently pay dividends.
What is Medavail Holdings, Inc.’s EPS estimate?
Medavail Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medavail Holdings, Inc. have?
Medavail Holdings, Inc. has 1,613,911 shares outstanding.
What happened to Medavail Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Medavail Holdings, Inc.?
Currently, no hedge funds are holding shares in MDVLQ
---
Company Description
Medavail Holdings, Inc.
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies aimed at maintaining or improving the health and performance of muscle tissue. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
---
MDVLQ Earnings Call
Q1 2023
0:00 / 0:00
---
Mind Medicine
―
ATAI Life Sciences
―
Biodesix
―
SELLAS Life Sciences Group
―
T2 Biosystems
―
OncoCyte
―
---